THIS EVENT WAS ORGANISED IN PARTNERSHIP WITH:
Global leader in Data-Driven Medicine, SOPHiA GENETICS is a health tech company which has developed SOPHiA Artificial Intelligence (AI), the most advanced technology for clinical genomics, helping healthcare professionals better diagnose and treat patients. The global network of over 450 institutions from 60 countries that use the SOPHiA DDM® analytical platform powered by SOPHiA form the world’s largest clinical genomics community.By enabling the rapid adoption of genomic testing worldwide, turning data into actionable clinical insights, and sharing knowledge through its community, SOPHiA GENETICS is democratizing Data-Driven Medicine to help save lives.
Covaris is the recognized industry leader for DNA fragmentation. Adaptive Focused Acoustics® (AFA™) is the gold standard for shearing DNA and RNA in Next-Generation Sequencing applications, without GC bias or thermal-induced damage. The Covaris AFA process is extensively cited in peer-reviewed research articles on DNA fragmentation using all available NGS systems. Covaris Focused-ultrasonicators are recommended by all major sequencing platform providers, and are used by leading Genome Centers worldwide including: the Wellcome Trust Sanger Institute, the Broad Institute, and BGI. For more information, please visit: www.covaris.com.
With a portfolio of more than 3,500 products covering the fields of genomics, protein analysis and expression, cellular analysis, drug discovery and genetic identity, Promega is a global leader in providing innovative solutions and technical support to life scientists in academic, industrial and government settings.
Promega products are used by life scientists who are asking fundamental questions about biological processes as well as by scientists who are applying scientific knowledge to diagnose and treat diseases, discover new therapeutics, and use genetics and DNA testing for human identification.
Promega holds significant intellectual property rights and licenses in several key areas that form a foundation for its diverse portfolio including:
– Bioluminescence, including engineered luciferases, luciferase reporter vectors and luciferase substrates
– Short tandem repeat (STR) detection for STR-based cell line authentication, human identification, cell and tissue characterisation, and mixed sample detection
– HaloTag® protein labelling and capture technology
Promega supports customers through providing the highest quality products, the best possible customer service, unsurpassed technical support, and many tools and resources for scientists are available online and on several mobile platforms.
Please visit our website: www.promega.com
Newmarket Scientific is a provider of kits and reagents for Next Generation Sequencing, including the NEXTflex range of library prep kits, amplicon panels and barcodes
Diagenode is a leading provider of complete solutions for epigenetics research and sample preparation. The company has developed solutions for a comprehensive approach to gain insights into DNA, RNA, and chromatin studies. Diagenode offers innovative reagent solutions and instruments to streamline next generation sequencing assays including library preparation solutions, DNA and chromatin shearing, low input RNA-sequencing, full automation platforms, as well as DNA methylation and ChIP-seq workflows. The company’s latest innovations include CATS-based RNA sequencing for low and difficult inputs and a full suite of epigenetics and NGS assay services. For more information about Diagenode, please visit the company’s website at www.diagenode.com.
At Twist Bioscience, we work in service of people who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals and data storage, our unique silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers.
Headquartered in Pleasanton, California, the Roche Sequencing Unit is focused on developing novel sequencing technologies and products to support innovation in clinical research applications. Our goal is to develop assays for sequencing, and refine sequencing techniques to advance sequencing technologies that will deliver truly differentiated clinical value.
Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give them the highest confidence in our solutions.
Agilent focuses its expertise on six key markets that involve Food, Environmental & Forensics, Diagnostics, Pharmaceutical, Chemical & Energy and Research, where we help our customers achieve their goals.
From the Diagnostics and Research part, Agilent gives doctors a head start in the fight against cancer and other diseases. Our solutions help pathology laboratories deliver fast, accurate information to the doctors, hospitals and medical centers they serve. We help medical professionals make more accurate diagnoses so patients can receive the most effective therapies.
Most life sciences and diagnostics research is done at top-tier universities, with funding from governments around the world. Agilent is helping these researchers learn more about cancer, cardiovascular diseases, diabetes, Alzheimer’s, Parkinson’s, autism and other ailments. Our instruments, software and sample preparation solutions help scientists conduct faster, more accurate research.
Read about the Agilent products and solutions that serve these markets.
Discuss your laboratory needs with an Agilent expert.
Frontiers in Genetics publishes rigorously peer-reviewed research on genes and genomes relating to all the domains of life, from humans to plants to livestock and other model organisms. Led by an outstanding Editorial Board of the world’s leading experts, this multidisciplinary, open-access journal is at the forefront of communicating cutting-edge research to researchers, academics, clinicians, policy makers and the public. The study of inheritance and the impact of the genome on various biological processes is well documented. However, the majority of discoveries are still to come. A new era is seeing major developments in the function and variability of the genome, the use of genetic and genomic tools and the analysis of the genetic basis of various biological phenomena. Frontiers in Genetics covers many areas of research from Genetic Disorders to Genomic Medicine and comprises the full spectrum of genetic and genomic inquiry, from the most basic to the most clinically applied, incorporating methodology, applications, and implications.